{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:52:50Z","timestamp":1789167170092,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010905","name":"Major Research Plan of National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010905","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.intimp.2026.117132","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T07:21:02Z","timestamp":1784272862000},"page":"117132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["m6A-modified lncRNA MIAT promotes anoikis resistance and peritoneal metastasis of colorectal cancer through miR-181a-5p\/MCL1 signaling axis"],"prefix":"10.1016","volume":"186","author":[{"given":"Lin","family":"Shu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liucui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruorui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maohui","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.117132_bb0005","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.intimp.2026.117132_bb0010","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.semcancer.2021.04.007","article-title":"Integrated approaches for precision oncology in colorectal cancer: the more you know, the better","volume":"84","author":"Andrei","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.intimp.2026.117132_bb0015","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S1470-2045(19)30390-0","article-title":"Study evidence confirms current clinical practice in refractory metastatic colorectal cancer: the ReDOS trial","volume":"20","author":"Hofheinz","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.intimp.2026.117132_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-021-00326-6","article-title":"Primary and metastatic peritoneal surface malignancies","volume":"7","author":"Cort\u00e9s-Guiral","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.intimp.2026.117132_bb0025","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s11605-019-04441-4","article-title":"Peritoneal metastases in colorectal cancer: biology and barriers","volume":"24","author":"Xue","year":"2020","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.intimp.2026.117132_bb0030","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/path.3000","article-title":"Anoikis: an emerging hallmark in health and diseases","volume":"226","author":"Taddei","year":"2012","journal-title":"J. Pathol."},{"key":"10.1016\/j.intimp.2026.117132_bb0035","doi-asserted-by":"crossref","first-page":"e718","DOI":"10.1002\/mco2.718","article-title":"Anoikis in cell fate, physiopathology, and therapeutic interventions","volume":"5","author":"Mei","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.intimp.2026.117132_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101099","article-title":"Targeting anoikis resistance as a strategy for cancer therapy","volume":"75","author":"Wang","year":"2024","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.intimp.2026.117132_bb0045","doi-asserted-by":"crossref","first-page":"7545","DOI":"10.7150\/thno.46001","article-title":"Nuclear MYH9-induced CTNNB1 transcription, targeted by staurosporin, promotes gastric cancer cell anoikis resistance and metastasis","volume":"10","author":"Ye","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.intimp.2026.117132_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-022-02381-7","article-title":"CircCEMIP promotes anoikis-resistance by enhancing protective autophagy in prostate cancer cells","volume":"41","author":"Yu","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2026.117132_bb0055","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","article-title":"Long non-coding RNAs: definitions, functions, challenges and recommendations","volume":"24","author":"Mattick","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.intimp.2026.117132_bb0060","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","article-title":"Gene regulation by long non-coding RNAs and its biological functions","volume":"22","author":"Statello","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.intimp.2026.117132_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107753","article-title":"Enhancer-driven lncRNA BDNF-AS induces endocrine resistance and malignant progression of breast Cancer through the RNH1\/TRIM21\/mTOR cascade","volume":"31","author":"Lin","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.intimp.2026.117132_bb0070","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1158\/0008-5472.CAN-14-1192","article-title":"Long noncoding RNA HULC modulates abnormal lipid metabolism in hepatoma cells through an miR-9-mediated RXRA signaling pathway","volume":"75","author":"Cui","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2026.117132_bb0075","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41419-018-0759-7","article-title":"LncRNA SNHG7 sponges miR-216b to promote proliferation and liver metastasis of colorectal cancer through upregulating GALNT1","volume":"9","author":"Shan","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2026.117132_bb0080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40164-021-00234-1","article-title":"Function and clinical significance of N6-methyladenosine in digestive system tumours","volume":"10","author":"Huang","year":"2021","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.intimp.2026.117132_bb0085","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-019-0805-7","article-title":"The interplay between m6A RNA methylation and noncoding RNA in cancer","volume":"12","author":"Ma","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.intimp.2026.117132_bb0090","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature12730","article-title":"N6-methyladenosine-dependent regulation of messenger RNA stability","volume":"505","author":"Wang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.117132_bb0095","doi-asserted-by":"crossref","first-page":"7239","DOI":"10.1093\/nar\/gkab378","article-title":"A comprehensive review of m6A\/m6Am RNA methyltransferase structures","volume":"49","author":"Oerum","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.intimp.2026.117132_bb0100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13045-020-00951-w","article-title":"Roles of METTL3 in cancer: mechanisms and therapeutic targeting","volume":"13","author":"Zeng","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.intimp.2026.117132_bb0105","article-title":"m6A modification on the fate of colorectal cancer: functions and mechanisms of cell proliferation and tumorigenesis","volume":"13","author":"Jiang","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2026.117132_bb0110","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13062-023-00393-7","article-title":"Pro-tumorigenic role of lnc-ZNF30-3 as a sponge counteracting miR-145-5p in prostate cancer","volume":"18","author":"Le Hars","year":"2023","journal-title":"Biol. Direct"},{"key":"10.1016\/j.intimp.2026.117132_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111412","article-title":"Long non-coding RNA LNC-POTEM-4 promotes HCC progression via the LNC-POTEM-4\/miR-149-5p\/Wnt4 signaling axis","volume":"124","author":"Lin","year":"2024","journal-title":"Cell. Signal."},{"key":"10.1016\/j.intimp.2026.117132_bb0120","article-title":"Lnc-MICAL2-1 sponges miR-25 to regulate DKK3 expression and inhibits activation of the Wnt\/\u03b2-catenin signaling pathway in breast cancer","volume":"49","author":"Yao","year":"2022","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.intimp.2026.117132_bb0125","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.bbrc.2014.06.142","article-title":"MiR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-met","volume":"450","author":"Korhan","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2026.117132_bb0130","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1007\/s12010-022-03943-3","article-title":"LncRNA LINC00665 promotes ovarian cancer cell proliferation and inhibits apoptosis via targeting miR-181a-5p\/FHDC","volume":"194","author":"Wang","year":"2022","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.intimp.2026.117132_bb0135","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cmet.2017.09.009","article-title":"MYC and MCL1 cooperatively promote chemotherapy-resistant breast cancer stem cells via regulation of mitochondrial oxidative phosphorylation","volume":"26","author":"Lee","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2026.117132_bb0140","doi-asserted-by":"crossref","first-page":"8806","DOI":"10.1038\/s41467-025-64042-5","article-title":"Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer","volume":"16","author":"Jim\u00e9nez-Vacas","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.117132_bb0145","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1073\/pnas.1814742116","article-title":"MGMT-activated DUB3 stabilizes MCL1 and drives chemoresistance in ovarian cancer","volume":"116","author":"Wu","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2026.117132_bb0150","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10585-022-10172-9","article-title":"Understanding the cell survival mechanism of anoikis-resistant cancer cells during different steps of metastasis","volume":"39","author":"Khan","year":"2022","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.intimp.2026.117132_bb0155","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature08268","article-title":"Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment","volume":"461","author":"Schafer","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.117132_bb0160","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-011162","article-title":"MIAT promotes tumor-infiltrating CD8(+) T-cell exhaustion and malignant progression of renal cell carcinoma via activating JAK3\/STAT3 pathway","volume":"13","author":"Zhang","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.intimp.2026.117132_bb0165","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/s41419-021-04386-0","article-title":"LncRNA-MIAT promotes thyroid cancer progression and function as ceRNA to target EZH2 by sponging miR-150-5p","volume":"12","author":"Guo","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2026.117132_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241311149","article-title":"MCL1 inhibition overcomes the aggressiveness features of triple-negative breast Cancer MDA-MB-231 cells","volume":"24","author":"Pratelli","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.117132_bb0175","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41419-025-07481-8","article-title":"Both direct and indirect suppression of MCL1 synergizes with BCLXL inhibition in preclinical models of gastric cancer","volume":"16","author":"Zhang","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2026.117132_bb0180","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s41419-021-04073-0","article-title":"Constitutive BAK\/MCL1 complexes predict paclitaxel and S63845 sensitivity of ovarian cancer","volume":"12","author":"Liu","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2026.117132_bb0185","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/jhbp.354","article-title":"Anoikis-resistant cholangiocarcinoma cells display aggressive characteristics and increase STAT3 activation","volume":"23","author":"Huyen","year":"2016","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"10.1016\/j.intimp.2026.117132_bb0190","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-021-01447-y","article-title":"METTL3\/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N(6)-methyladenosine modification of PD-L1 mRNA in breast cancer","volume":"21","author":"Wan","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.intimp.2026.117132_bb0195","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1136\/gutjnl-2019-319639","article-title":"METTL3-mediated m(6)a modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance","volume":"69","author":"Wang","year":"2020","journal-title":"Gut"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926009781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926009781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:44:01Z","timestamp":1786322641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926009781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":39,"alternative-id":["S1567576926009781"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117132","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"m6A-modified lncRNA MIAT promotes anoikis resistance and peritoneal metastasis of colorectal cancer through miR-181a-5p\/MCL1 signaling axis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117132","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117132"}}